The Latin America, Middle East and Africa Head And Neck Cancer Therapeutics Market would witness market growth of 19.5% CAGR during the forecast period (2022-2028).
If a head and neck squamous cell carcinoma is to spread, it nearly always does so locally and/or to the neck lymph nodes. Sometimes, malignant squamous cells can be discovered in the lymph nodes of the upper neck despite the absence of cancer in other areas of the head and neck, probably because the source tumor was too small.
This condition is characterized as metastatic squamous cell carcinoma with an unknown (occult) source. Liquor and nicotine consumption (including passive smoking and smokeless tobacco, sometimes known as "chewing tobacco" or "snuff") are the two most significant risk factors for head and neck malignancies, particularly those of the oral cavity, hypopharynx, and voice box.
People who use both cigarettes and alcohol are more likely to acquire these malignancies than those who use either substance alone. The majority of oral and laryngeal squamous cell carcinomas of the head and neck are caused by cigarette and alcohol use. Infection with cancer-causing human papillomavirus (HPV), particularly HPV type 16, is a risk factor for oropharyngeal malignancies involving the tonsils or the base of the tongue.
Head and neck cancer (HNC) are largely a disease in the developing world. Overall, 67% of HNC and 82% of HNC-related mortality occur in developing nations. Despite this significant cancer burden, emerging nations only represent 5% of worldwide cancer expenditures. Between 2010 and 2030, the incidence and death rates of cancer in Africa are projected to nearly double. Two-thirds of patients come with advanced malignancies, while 50% of laryngectomee patients in Cape Town require emergency tracheostomy. In impoverished nations, inquiry and therapy are difficult to get.
The Brazil market dominated the LAMEA Head & Neck Cancer Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $50.3 Million by 2028. The Argentina market is experiencing a CAGR of 20.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 19.2% during (2022 - 2028).
Based on Therapy Type, the market is segmented into Immunotherapy, Chemotherapy, and Targeted Therapy. Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Head And Neck Cancer Therapeutics Market is Predict to reach $2.5 Billion by 2028, at a CAGR of 12.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Bristol Myers Squibb Company, and Clinigen Group PLC.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
- Immunotherapy
- Chemotherapy
- Targeted Therapy
By Route of Administration
By Distribution Channel
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceuticals Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- AstraZeneca Plc
- Bristol Myers Squibb Company
- Clinigen Group PLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Head & Neck Cancer Therapeutics Market, by Therapy Type
1.4.2 LAMEA Head & Neck Cancer Therapeutics Market, by Route of Administration
1.4.3 LAMEA Head & Neck Cancer Therapeutics Market, by Distribution Channel
1.4.4 LAMEA Head & Neck Cancer Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Head And Neck Cancer Therapeutics Market
Chapter 4. LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type
4.1 LAMEA Immunotherapy Market by Country
4.2 LAMEA Chemotherapy Market by Country
4.3 LAMEA Targeted Therapy Market by Country
Chapter 5. LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration
5.1 LAMEA Injectable Market by Country
5.2 LAMEA Oral Market by Country
Chapter 6. LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel
6.1 LAMEA Retail & Specialty Pharmacies Market by Country
6.2 LAMEA Hospital Pharmacies Market by Country
6.3 LAMEA Online Pharmacies Market by Country
Chapter 7. LAMEA Head & Neck Cancer Therapeutics Market by Country
7.1 Brazil Head & Neck Cancer Therapeutics Market
7.1.1 Brazil Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.2 Brazil Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.3 Brazil Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2 Argentina Head & Neck Cancer Therapeutics Market
7.2.1 Argentina Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.2 Argentina Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.3 Argentina Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3 UAE Head & Neck Cancer Therapeutics Market
7.3.1 UAE Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.2 UAE Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.3 UAE Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4 Saudi Arabia Head & Neck Cancer Therapeutics Market
7.4.1 Saudi Arabia Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.2 Saudi Arabia Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.3 Saudi Arabia Head & Neck Cancer Therapeutics Market by Distribution Channel
7.5 South Africa Head & Neck Cancer Therapeutics Market
7.5.1 South Africa Head & Neck Cancer Therapeutics Market by Therapy Type
7.5.2 South Africa Head & Neck Cancer Therapeutics Market by Route of Administration
7.5.3 South Africa Head & Neck Cancer Therapeutics Market by Distribution Channel
7.6 Nigeria Head & Neck Cancer Therapeutics Market
7.6.1 Nigeria Head & Neck Cancer Therapeutics Market by Therapy Type
7.6.2 Nigeria Head & Neck Cancer Therapeutics Market by Route of Administration
7.6.3 Nigeria Head & Neck Cancer Therapeutics Market by Distribution Channel
7.7 Rest of LAMEA Head & Neck Cancer Therapeutics Market
7.7.1 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type
7.7.2 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration
7.7.3 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.2 Merck & Co., Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Takeda Pharmaceutical Company Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Bristol Myers Squibb Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Clinigen Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
TABLE 1 LAMEA Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Chemotherapy Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Chemotherapy Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Targeted Therapy Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Targeted Therapy Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 LAMEA Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 27 Brazil Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 Brazil Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 Brazil Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 30 Brazil Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 31 Brazil Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 32 Brazil Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 33 Brazil Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 Brazil Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 Argentina Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 36 Argentina Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 37 Argentina Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 38 Argentina Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 39 Argentina Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 40 Argentina Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 41 Argentina Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 Argentina Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 UAE Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 44 UAE Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 45 UAE Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 46 UAE Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 47 UAE Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 48 UAE Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 49 UAE Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 UAE Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 Saudi Arabia Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 52 Saudi Arabia Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 53 Saudi Arabia Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 54 Saudi Arabia Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 South Africa Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 60 South Africa Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 61 South Africa Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 62 South Africa Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 63 South Africa Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 64 South Africa Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 65 South Africa Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 South Africa Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Nigeria Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 68 Nigeria Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 69 Nigeria Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 70 Nigeria Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 71 Nigeria Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 72 Nigeria Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 73 Nigeria Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Nigeria Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Rest of LAMEA Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 76 Rest of LAMEA Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 77 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 78 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 83 Key Information – Eli Lilly And Company
TABLE 84 KEY INFORMATION - MERCK & CO., INC.
TABLE 85 Key Information – Sanofi S.A.
TABLE 86 Key Information – Takeda Pharmaceutical Company Limited
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 89 KEY INFORMATION – AstraZeneca PLC
TABLE 90 Key Information – Bristol Myers Squibb Company
TABLE 91 Key Information – Clinigen Group PLC
List of Figures
FIG 1 Methodology for the research